Skip to content

Effect of infraspinatus-teres minor interfascial block on postoperative recovery in patients undergoing arthroscopic rotator cuff repair under general anesthesia combined with interscalene nerve block

Effect of infraspinatus-teres minor interfascial block on postoperative recovery in patients undergoing arthroscopic rotator cuff repair under general anesthesia combined with interscalene nerve block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114772
Enrollment
Unknown
Registered
2025-12-17
Start date
2025-12-19
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder arthroscopic repair

Interventions

Observation Group 1 of infraspinatus - teres minor muscle fascia nerve block:Inject 20 ml of 0.375% ropivacaine.
Observation of infraspinatus - teres minor muscle fascia nerve block in 2 groups:Inject 20 ml of 0.5% liposomal bupivacaine.
Control group:Inject 20 ml of normal saline.

Sponsors

Hengshui People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 75 years old, gender is not restricted. 2. Pre - operatively diagnosed with full - thickness rotator cuff tear by magnetic resonance imaging (MRI), and the tear range is <=5 cm. 3.Planned to undergo arthroscopic rotator cuff repair (ASRCR) under general anesthesia combined with interscalene brachial plexus block. 4.Classified as American Society of Anesthesiologists (ASA) physical status II -III. 5.Able to understand and cooperate to complete the visual analog scale (VAS), sleep quality and shoulder joint function assessment.

Exclusion criteria

Exclusion criteria: 1. Allergic to ropivacaine, bupivacaine liposome or normal saline; 2. Presence of infection, tumor or severe malformation in the infraspinatus and teres minor muscle regions; 3. Long - term use of opioids (=3 times/week) within 3 months before surgery or a history of drug abuse; 4. Complicated with severe mental illness (such as depression), cognitive impairment or inability to communicate normally; 5. Previous history of surgery on the same - side shoulder joint or neuropathy of the same - side shoulder joint.

Design outcomes

Primary

MeasureTime frame
The incidence of rebound tenderness before and after the resolution of ISB 8 - 48 hours after surgery (rebound tenderness was defined as NRS >= 7 points). In patients receiving regional anesthesia, rebound tenderness was usually observed 8 - 48 hours after surgery.;

Secondary

MeasureTime frame
Opioid use: including the total consumption of sufentanil (mg) in IV - PCA and the total dose of non - steroidal drugs for rescue analgesia (mg);Sleep quality: The Athens Insomnia Scale was used to evaluate the patients' sleep quality on the first and second nights after surgery (the scoring range is 0 - 10 points, with higher scores indicating poorer sleep quality). Meanwhile, the number of times the patients woke up at night due to pain was recorded.;Quality of Recovery - 15 (QoR-15): Evaluate the postoperative recovery quality of patients.;Shoulder joint function recovery: Measure the range of motion of the patient's shoulder joint (including the angles of forward flexion, abduction, and external rotation) at 1 week, 1 month, and 3 months after surgery respectively; at 3 months after surgery, use the Constant - Murley shoulder joint function score (the scoring range is 0 - 100 points, and a higher score indicates better shoulder joint function) to evaluate the recovery status of the patient's shoulder joint function.;

Countries

China

Contacts

Public ContactLiu Xiaomeng

Hengshui People's Hospital

614376946@qq.com+86 173 3183 3598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026